Project Grant S10OD040100
- Federal Project Grant Award Summary The National Institutes of Health Office of the Director awarded $1,022,134 to the University of Maryland, Baltimore under the Research Infrastructure Programs (CFDA 93.351) on September 25, 2025, for a one-year performance period ending September 24, 2026. This Project Grant supports the establishment and operation of advanced shared research infrastructure at UMB's newly constructed Health Science Facility III, specifically leveraging integrated Positron...
- Federal Project Grant Award Summary The University of Maryland, Baltimore (UMB) received a $674,156 Project Grant award from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on May 15, 2026, with a completion date of May 14, 2027. The award funds the acquisition and installation of a Thermo Fisher Scientific Talos L120C G2 120 kilovolt transmission electron microscope (TEM) to replace a decommissioned 20-year-old instrument at...
- Federal Grant Award Summary The University of Maryland, Baltimore (UMB) received a $699,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to procure and install a state-of-the-art helium recovery system within the UMB Nuclear Magnetic Resonance (NMR) Core Facility. The award, effective July 1, 2025, through June 30, 2027, will enable the institution to recover and recycle liquid helium used to...
- Federal Grant Award Summary The University of Maryland, Baltimore (UMB) received a $750,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a Nanion Technologies Syncropatch 384 automated patch-clamp instrument. The award, obligated on May 1, 2026 with completion targeted for April 30, 2027, supports the purchase of specialized electrophysiology equipment that will enable high-throughput...
- Federal Grant Award Summary This $197,930 Project Grant, awarded September 16, 2025, by the National Institutes of Health Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), supports research at Lawrence Berkeley National Laboratory to develop a non-invasive biodosimeter for radiation exposure assessment during radiological emergencies. The project leverages Fourier Transform Infrared Attenuated Total Reflection (FTIR-ATR) imaging combined with statistical...
- Federal Grant Award Summary The University of Maryland, College Park received a $391,162 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 10, 2025 through July 31, 2030. This Early-Stage Investigator Maximizing Investigators Research Award (ESI MIRA) funds the Biological Engineering for Advanced Drug Delivery (BEADD) Laboratory to conduct fundamental research on the...
- Federal Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded $703,623.00 to the University of California, Davis under the Research Infrastructure Programs (CFDA 93.351) to upgrade the Bruker 7T preclinical magnetic resonance imaging (MRI) system at the UC Davis Center for Molecular and Genomic Imaging. The project, which commenced May 1, 2026 and concludes April 30, 2027, involves replacing the end-of-life Bruker Avance III console installed in 2010 with a...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded The Johns Hopkins University $999,928 under the Research Infrastructure Programs (CFDA 93.351) to acquire a high-resolution small animal Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) system equipped with cadmium zinc telluride (CZT) detectors. This High-End Instrumentation grant, effective from July 15, 2025, through July 14, 2026, will support Johns Hopkins'...
- Federal Grant Award Summary The University of Maryland, Baltimore received a $428,432 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) effective September 1, 2025, through August 31, 2026. This award funds research combining experimental, computational, and artificial intelligence (AI) approaches to interrogate the pharmacology and mechanisms of action of fentanyl and nitazene...
- Federal Project Grant Award Summary The University of Maryland, Baltimore received a $4.52 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2025, through September 29, 2029. The award funds a first-in-human Phase 1 clinical trial investigating trispecific chimeric antigen receptor (CAR) T cells targeting CD19/CD20/CD22 for the treatment of relapsed/refractory B cell lymphoma. The...
The University of Maryland, Baltimore received a $418,255 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) for the period May 1, 2026 through April 30, 2027. The award funds the acquisition and installation of an X-RAD 320 irradiator equipped with OPTIMAX imaging technology to replace aging radiation delivery equipment at the Division of Translational Radiation Sciences (DTRS). This state-of-the-art instrument will support both in vitro and in vivo irradiation procedures for investigators conducting research through two NIH-sponsored consortia—the Intercollaborative Radiation Countermeasures (INTERACT) Consortium and the Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OLIGOMET)—as well as other campus researchers requiring precise radiation dose delivery capabilities. The modernized equipment addresses critical infrastructure needs by replacing the institution's increasingly unreliable XRAD-320 X-ray irradiator, for which manufacturer support and preventive maintenance are no longer available, and facilitates compliance with National Defense Authorization Act mandates requiring elimination of cesium-137 irradiators by December 31, 2027. As a fee-for-service facility, DTRS will continue to provide irradiation support services to a broad user base of investigators across campus through this modernized research infrastructure.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $418.3k | 5/1/26 |